Charles River Laboratories International, Inc.CRLNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank23
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P23
Within normal range
vs 3Y Ago
-1.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -10.15% |
| Q3 2025 | 33.62% |
| Q2 2025 | 34.10% |
| Q1 2025 | 144.53% |
| Q4 2024 | -242.83% |
| Q3 2024 | -22.58% |
| Q2 2024 | 20.38% |
| Q1 2024 | -5.22% |
| Q4 2023 | -12.26% |
| Q3 2023 | -8.15% |
| Q3 2023 | -1.76% |
| Q2 2023 | 2.49% |
| Q4 2022 | 8.50% |
| Q3 2022 | -19.44% |
| Q2 2022 | 25.97% |
| Q1 2022 | -13.91% |
| Q4 2021 | 10.91% |
| Q3 2021 | 13.27% |
| Q2 2021 | 11.19% |
| Q1 2021 | -4.05% |
| Q4 2020 | -2.88% |
| Q3 2020 | 72.93% |
| Q2 2020 | -18.58% |
| Q1 2020 | -13.34% |
| Q4 2019 | 17.23% |
| Q3 2019 | 16.34% |
| Q2 2019 | 14.29% |
| Q1 2019 | -31.90% |
| Q4 2018 | 21.48% |
| Q3 2018 | 9.98% |
| Q2 2018 | 13.09% |
| Q1 2018 | 8.13% |
| Q4 2017 | -15.30% |
| Q3 2017 | -9.33% |
| Q3 2017 | 17.19% |
| Q2 2017 | 0.89% |
| Q4 2016 | 17.51% |
| Q3 2016 | 1.26% |
| Q2 2016 | 12.80% |
| Q1 2016 | -1.52% |